Citations

Clear

20 citation(s) found for "Boyle, Mary".

Building a Central Repository for Research Ethics Consultation Data: A Proposal for a Standard Data Collection Tool
Cho, Mildred K. , Anderson, Nick, Barnard, David , Boyle, Mary B., Capron, Alexander Morgan , Dorfman, Elizabeth, Havard, Kathryn, Reider, Carson, Sadler, John Z. , Sharp, Richard R. , Wilfond, Benjamin S. , McCormick, Jennifer B, Taylor, Holly A. , McCormick, Jennifer Blair , Anderson, Nick, Schwartz, Peter H. , Danis, Marion , Sharp, Richard R

Mayo Clinic

Clinical and Translational Science | March 10, 2015 | Volume: 8 | Issue: 4 | Pages: 376-387

10.1111/cts.12268 | PMID 25758372 Get It

AbstractClinical research ethics consultation services have been established across academic health centers over the past decade. This paper presents the results of collaboration within the CTSA consortium to develop a standard approach to the collection of research ethics consultation information to serve as a foundation for quality improvement, education, and research efforts. This approach includes categorizing and documenting descriptive information about the requestor, research project, the ethical question, the consult process, and describing the basic structure for a consult note. This paper also explores challenges in determining how to share some of this information between collaborating institutions related to concerns about confidentially, data quality, and informatics. While there is much still to be learned to improve the process of clinical research ethics consultation, these tools can advance these efforts, which, in turn, can facilitate the ethical conduct of research.
Insulin Pump Therapy in the Perioperative Period: A Review of Care after Implementation of Institutional Guidelines
Boyle, Mary E., Seifert, Karen M., Beer, K, Schlinkert, Richard T., Stearns, Joshua D., Mackey, Patricia , Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 6 | Issue: 5 | Pages: 1016-1021

10.1177/193229681200600504 | PMID 23063026 Get It

Background: An institutional policy was previously established for patients with diabetes on insulin pump therapy undergoing elective surgical procedures. Method: Electronic medical records were reviewed to assess documentation of insulin pump status and glucose monitoring during preoperative, intraoperative, and postanesthesia care unit (PACU) phases of care. Results: Twenty patients with insulin pumps underwent 23 procedures from March 1 to December 31, 2011. Mean (standard deviation) age was 58 (13) years, mean diabetes duration was 28 (17) years, and mean duration of insulin pump therapy was 7 (6) years. Nearly all cases (86%) during the preoperative phase had the presence of the device documented—an improvement over the 64% noted in data collected before the policy. Intraoperatively, 13 cases (61%) had the presence of the pump documented, which was higher than the 28% before implementation of the policy. However, documentation of pump status was found in only 38% in the PACU and was actually less than the 60% documented previously. Over 90% of cases had glucose checked in the preoperative area and the PACU, and only 60% had it checked intraoperatively, which was nearly identical to the percentages seen before policy implementation. No adverse events occurred when insulin pump therapy was continued. Conclusions: Although some processes still require improvement, preliminary data suggest that the policy for perioperative management of insulin pumps has provided useful structure for care of these cases. The data thus far indicate that insulin pump therapy can be continued safely during the perioperative period.
Transitioning Insulin Pump Therapy from the Outpatient to the Inpatient Setting: A Review of 6 Years' Experience with 253 Cases
Beer, K, Seifert, Karen M., Boyle, Mary E., Castro, Janna C. , Cook, Curtiss B. , Mackey, Patricia

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 6 | Issue: 5 | Pages: 995-1002

10.1177/193229681200600502 | PMID 23063024 Get It

Background: We reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay. Methods: Records were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011. Results: A total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65%) hospitalizations. Adherence to core process measures improved over time: by 2011, 100% of cases had an endocrinology consultation, 100% had the required insulin pump order set completed, and 94% had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64% of cases by the end of 2011. Mean glucose was not significantly different among patients who remained on insulin pump therapy compared to those for whom it was discontinued ( p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy. Conclusions: With appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.
Guidelines for Application of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Perioperative Period
Boyle, Mary E., Seifert, Karen M., Beer, K, Apsey, Heidi A., Nassar, Adrienne A., Littman, Stephanie D., Magallanez, Janice M., Schlinkert, Richard T., Stearns, Joshua D., Hovan, Michael J., Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 6 | Issue: 1 | Pages: 184-190

10.1177/193229681200600123 | PMID 22401338 Get It

Case reports indicate that diabetes patients receiving outpatient insulin pump therapy have been allowed to continue treatment during surgical procedures. Although allowed during surgery, there is actually little information in the medical literature on how to manage patients receiving insulin pump therapy during a planned surgical procedure. A multidisciplinary work group reviewed current information regarding the use of insulin pumps in the perioperative period. Although the work group identified safety issues specific to surgical scenarios, it believed that with the use of standardized guidelines and a checklist, continuation of insulin pump therapy during the perioperative period is feasible. A sample set of protocols have been developed and are summarized. A policy outlining clear procedures should be established at the institutional level to guide physicians and other staf if the devices are to be employed during the perioperative period. Additional clinical experience with the technology in surgical scenarios is needed, and consensus should be developed for insulin pump use in the perioperative phases of care.
Diabetes in the Desert: What Do Patients Know about the Heat?
Nassar, Adrienne A., Childs, Raymond D., Boyle, Mary E., Jameson, Kimberly A. , Fowke, Margaret, Waters, Ken R., Hovan, Michael J., Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 4 | Issue: 5 | Pages: 1156-1163

10.1177/193229681000400514 | PMID 20920435 Get It

Background: This study aims to identify self-management strategies used by patients with diabetes in hot weather, examine knowledge of safe temperatures and exposure times, and evaluate comprehension of weather data. Methods: Patients attending an endocrinology clinic in southwestern United States were surveyed. Results: One hundred fifty-two surveys completed from November 30 to December 31, 2009 were analyzed. Mean patient age was 64 years; diabetes duration, 15 years; 51% were women, 83% had type 2 diabetes, 58% were non Hispanic white, and 77% were on insulin injections. Mean hemoglobin A1c was 7.9%; 38% had hemoglobin A1c values of 8.0% or higher. Patients used an array of personal protective measures during hot weather, and 71% limited heat exposure to less than one hour. Respondents typically took steps to protect their diabetes medication and supplies, but 37% chose to leave medications and supplies at home. Although 73% of respondents had received information regarding the effect of heat on insulin, only 39% had received information about the effect of heat on oral medications, 41% on glucose meters, and 38% on glucose test strips. The temperature at which patients took protective measures varied. Only 55% knew the definition of the heat index. Conclusion: Most survey participants took measures to protect themselves from the heat, although gaps in knowledge were evident. Many patients had suboptimal glycemic control, placing them potentially at risk for dehydration during the hottest months. Increased public awareness of this topic is needed, and diabetes education programs should include information about the heat where appropriate.
Outpatient-to-Inpatient Transition of Insulin Pump Therapy: Successes and Continuing Challenges
Nassar, Adrienne A., Partlow, Brenda, Boyle, Mary E., Castro, Janna C. , Bourgeois, Peggy B., Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 4 | Issue: 4 | Pages: 863-872

10.1177/193229681000400415 | PMID 20663450 Get It

Background: Insulin pump therapy is a complex technology prone to errors when employed in the hospital setting. When patients on insulin pump therapy require hospitalization, practitioners caring for them must decide whether to allow continued pump use. We provide the largest review regarding transitioning insulin pump therapy from the outpatient to inpatient setting. Method: Records of inpatient insulin pump users were retrospectively analyzed at a metropolitan Phoenix hospital between January 2006 and December 2009. Adherence to institutional procedures on insulin pump use was assessed, glycemic control was determined, and adverse events were examined. Results: We examined records on 65 patients with insulin pumps, totaling 125 hospitalizations. Mean (standard deviation) patient age was 55 (17) years, diabetes duration was 27 (14) years, pump duration was 6 (5) years, length of hospital stay was 4.7 (6.3) days, hemoglobin A1c was 7.3 (1.3)%, 85% had type 1 diabetes mellitus, 57% were women, and 97% were white. Admissions involving insulin pumps increased (23 in 2006, 17 in 2007, 40 in 2008, and 45 in 2009). Insulin pump therapy was continued in 83 (66%) hospitalizations. Among these hospitalizations, endocrinology consultations were obtained in 89%, consent agreements were found in 83%, insulin pump order sets were completed in 89%, admission glucose was checked in 100%, and nursing assessments of pump insertion sites were documented in 89%, but bedside insulin pump flow sheets were found in only 55%. Mean glucose of 175 (57) mg/dl was not significantly different than that in hospitalizations where insulin pumps were discontinued [175 (42) mg/dl] or used intermittently [177 (7) mg/dl]. There was one instance of a pump catheter kinking; however, no other adverse events (pump site infections, mechanical pump failure, diabetic ketoacidosis) were observed, and there were no use-related fatalities. Conclusions: Most patients using insulin pumps can safely have their therapy transitioned when hospitalized. A policy on inpatient continuous subcutaneous insulin infusion use can be successfully implemented. Compliance with required procedures can be achieved, although there was room to improve adherence with some process measures. Further study is needed to determine how to optimize glycemic control when pumps are allowed during hospitalization.
Temporal and Geographic Patterns of Hypoglycemia among Hospitalized Patients with Diabetes Mellitus
Bailon, Rachel M., Hovan, Michael J., Hull, Bryan P., Seifert, Karen M., Miller-Cage, Victoria, Beer, K, Boyle, Mary E., Littman, Stephanie D., Magallanez, Janice M., Fischenich, Joanne M., Harris, Jana K., Scoggins, Susie S., Uy, Josephine, Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 3 | Issue: 2 | Pages: 261-268

10.1177/193229680900300206 | PMID 20144357 Get It

Background: Hypoglycemia is often cited as a barrier to achieving inpatient glycemic targets. We sought to characterize hypoglycemic events in our institution by work-shift cycle and by specific treatment area. Methods: Capillary (bedside) and blood (laboratory) glucose values of <70 mg/dl for patients with either a known diagnosis of diabetes or with evidence of hyperglycemia were abstracted from our laboratory database for hospitalizations between October 1, 2007, and February 3, 2008. Hypoglycemic events were analyzed by 12 h nursing work-shift cycles (day shift, 07:00 to 18:59; night shift, 19:00 to 06:59) and by the six medical, surgical, and intensive care areas in the hospital (designated areas 1 to 6). Results: We identified 206 individual patients with either diabetes or hyperglycemia (mean age, 67 years; 56% men; 83% white) who had 423 hypoglycemic events. There were 78% more hypoglycemic events during the night shift ( n = 271 events in 128 individual patients) than during the day shift ( n = 152 events in 96 individual patients). Most of the night-shift hypoglycemic measurements were detected between 04:00 and 04:59 or 06:00 and 06:59. The mean hypoglycemic level was comparable between shifts ( p = .79) and across the six inpatient areas. The number of hypoglycemic events per person increased with lengths of hospital stay >5 days. The prevalence of hypoglycemia varied across patient care areas within the hospital, with most (28%) detected in one area of the hospital. Conclusion: There are temporal and geographic patterns in the occurrence of hypoglycemia among patients with diabetes or hyperglycemia in our hospital. Further study should focus on the reasons underlying these variations so that specific interventions can address the risk of hypoglycemia during peak times and places.
Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital: A Review of One Institution's Experience
Leonhardi, Brenda J., Boyle, Mary E., Beer, K, Seifert, Karen M., Bailey, Marilyn, Miller-Cage, Victoria, Castro, Janna C. , Bourgeois, Peggy B., Cook, Curtiss B.

Mayo Clinic

Journal of Diabetes Science and Technology | January 10, 2014 | Volume: 2 | Issue: 6 | Pages: 948-962

10.1177/193229680800200605 | PMID 19885284 Get It

Background: This article reviews the performance of our hospital's inpatient insulin pump policy. Methods: Twenty-five hospital admissions of 21 unique patients receiving outpatient insulin pump therapy were reviewed. Results: Between November 1, 2005, and November 30, 2006, there were 25 hospital admissions involving 21 patients receiving outpatient insulin pump therapy. The average age and duration of diabetes among these 21 patients was 50 and 29 years, respectively; 67% were women, 90% had type 1 diabetes, and all were white. The mean length of hospital stay was 4 days, and the average reported length of insulin pump therapy was 4 years. Patients in 16 of the admissions were identified as candidates for continued use of the insulin pump during the hospital stay. Over 90% of patients remaining on the insulin pump had documentation by nursing of the presence of the pump at the time of admission; 100% of the patients had an admission glucose recorded; 88% had a record of signed patient consent; 81% had evidence of completed preprinted insulin pump orders; 75% received a required endocrine consultation; and 75% of cases had documentation of completed bedside flow sheet. A high frequency of both hypoglycemic and hyperglycemic events occurred in the patients; however, no adverse events were related directly to the insulin pump. Conclusions: Insulin pump therapy can be safely continued in the hospital setting. While staff compliance with required procedures was high, there was still room for improvement. More data are needed, however, on whether this method of insulin delivery is effective for controlling hyperglycemia in hospitalized patients.
Beliefs About Hospital Diabetes and Perceived Barriers to Glucose Management Among Inpatient Midlevel Practitioners
Jameson, Kimberly A. , Hartsell, Zachary, Boyle, Mary E., Leonhardi, Brenda J., Farquhar-Snow, Marci, Beer, K, Cook, Curtiss B.

Mayo Clinic

The Diabetes Educator | February 11, 2008 | Volume: 34 | Issue: 1 | Pages: 75-83

10.1177/0145721707311957 | PMID 18267993 Get It

Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital Setting
Boyle, Mary E., Cisar, Nancy, Miller-Cage, Victoria, Bourgeois, Peggy B., Roust, Lori R., Smith, Steven A., Zimmerman, Richard S. , Cook, Curtiss B.

Mayo Clinic

The Diabetes Educator | November 15, 2005 | Volume: 31 | Issue: 6 | Pages: 849-857

10.1177/0145721705281563 | PMID 16288092 Get It

Purpose Individuals whose diabetes is being treated in the outpatient setting via an insulin pump often wish to maintain this therapy during hospitalization. The authors propose guidelines for management of patients on insulin pumps who require a hospital admission. Methods A collaborative interinstitutional task force reviewed current available information regarding the use of insulin pumps in the hospital. Results There was little information in the medical literature on how to manage individuals on established insulin pump therapy during a hospital stay. The task force believed that a policy that promotes patient independence through continuation of insulin pump therapy while ensuring patient safety was possible. A set of contraindications for continued use of pump therapy in the hospital are proposed. A sample patient consent form and order set are presented. Finally, measures that can be used to assess effectiveness of an inpatient insulin pump policy are outlined. Conclusions Patients on established insulin pump therapy do not necessarily have to discontinue treatment while hospitalized. However, clear policies and procedures should be established at the institutional level to guide continued use of the technology in the acute care setting.